SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,232,751 | -77.0% | 18,419 | -78.3% | 0.02% | -75.0% |
| Q2 2023 | $9,726,112 | -28.2% | 84,929 | -13.5% | 0.06% | -22.9% |
| Q1 2023 | $13,538,490 | -25.0% | 98,226 | -29.5% | 0.08% | -21.0% |
| Q4 2022 | $18,059,176 | -19.1% | 139,367 | -31.0% | 0.10% | -16.0% |
| Q3 2022 | $22,318,000 | +192.0% | 201,897 | +98.0% | 0.12% | +166.0% |
| Q2 2022 | $7,643,000 | +55.9% | 101,962 | +62.5% | 0.05% | +14.6% |
| Q1 2022 | $4,902,000 | -46.4% | 62,753 | -38.3% | 0.04% | -52.9% |
| Q4 2021 | $9,154,000 | +46.2% | 101,653 | +50.1% | 0.09% | +10.1% |
| Q3 2021 | $6,263,000 | +41.2% | 67,725 | +18.7% | 0.08% | +58.0% |
| Q2 2021 | $4,436,000 | -38.3% | 57,060 | -40.9% | 0.05% | -45.7% |
| Q1 2021 | $7,192,000 | +817.3% | 96,502 | +1998.3% | 0.09% | +736.4% |
| Q4 2020 | $784,000 | -83.0% | 4,599 | -86.0% | 0.01% | -83.8% |
| Q3 2020 | $4,605,000 | +379.7% | 32,793 | +447.8% | 0.07% | +300.0% |
| Q2 2020 | $960,000 | -74.6% | 5,986 | -79.6% | 0.02% | -75.4% |
| Q4 2019 | $3,780,000 | -57.7% | 29,292 | -75.3% | 0.07% | -61.0% |
| Q3 2019 | $8,929,000 | +816.7% | 118,542 | +1749.9% | 0.18% | +883.3% |
| Q2 2019 | $974,000 | -45.7% | 6,408 | -57.4% | 0.02% | -69.0% |
| Q1 2019 | $1,793,000 | +395.3% | 15,044 | +353.4% | 0.06% | +241.2% |
| Q4 2018 | $362,000 | +32.6% | 3,318 | +96.6% | 0.02% | +13.3% |
| Q3 2018 | $273,000 | -73.5% | 1,688 | -78.4% | 0.02% | -71.2% |
| Q2 2018 | $1,031,000 | +1809.3% | 7,800 | +701.6% | 0.05% | +1633.3% |
| Q4 2017 | $54,000 | -33.3% | 973 | -45.5% | 0.00% | -40.0% |
| Q3 2017 | $81,000 | -47.7% | 1,786 | -61.2% | 0.01% | -50.0% |
| Q2 2017 | $155,000 | +146.0% | 4,600 | +116.4% | 0.01% | +150.0% |
| Q1 2017 | $63,000 | -53.3% | 2,126 | -57.0% | 0.00% | -63.6% |
| Q4 2016 | $135,000 | +694.1% | 4,939 | +1702.6% | 0.01% | +1000.0% |
| Q3 2016 | $17,000 | +240.0% | 274 | 0.0% | 0.00% | – |
| Q2 2016 | $5,000 | -99.1% | 274 | -99.1% | 0.00% | -100.0% |
| Q1 2016 | $584,000 | +209.0% | 29,905 | +511.1% | 0.03% | +200.0% |
| Q4 2015 | $189,000 | -68.0% | 4,894 | -73.4% | 0.01% | -63.3% |
| Q3 2015 | $590,000 | +972.7% | 18,389 | +921.6% | 0.03% | +900.0% |
| Q2 2015 | $55,000 | +358.3% | 1,800 | +101.1% | 0.00% | +200.0% |
| Q1 2015 | $12,000 | -73.9% | 895 | -58.8% | 0.00% | -66.7% |
| Q3 2014 | $46,000 | -59.3% | 2,174 | -42.8% | 0.00% | -57.1% |
| Q2 2014 | $113,000 | – | 3,802 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |